Pathogenic, immunologic, and clinical aspects of sepsis - update 2016

被引:11
|
作者
Uhle, Florian [1 ]
Chousterman, Benjamin G. [2 ,3 ]
Gruetzmann, Robert [4 ]
Brenner, Thorsten [1 ]
Weber, Georg F. [4 ]
机构
[1] Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany
[2] Hop Lariboisiere, AP HP, Dept Anesthesia Intens Care & SAMU, Paris, France
[3] Univ Paris Diderot, Paris, France
[4] Univ Hosp Erlangen Nurnberg, Dept Surg, Erlangen, Germany
关键词
Bacterial toxins; immune-pathophysiology; sepsis; biomarkers; microbiology; diagnostics; pathogen-host interaction; INTERNATIONAL CONSENSUS DEFINITIONS; INFLAMMATORY RESPONSE SYNDROME; GOAL-DIRECTED RESUSCITATION; NEUTROPHIL RECRUITMENT; INTENSIVE-CARE; SEPTIC SHOCK; IMMUNE-RESPONSE; HOST RESPONSE; DR EXPRESSION; THERAPY;
D O I
10.1080/14787210.2016.1224971
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Sepsis is a major cause of death worldwide but its orchestrating components remain incompletely understood. On the one hand, development of sepsis results from an infectious focus that cannot be controlled by the immune system, but on the other, responding immune cells that can eliminate the infection inflict damage to the host by contributing to complications such as endothelial leakage, septic shock, and multiorgan failure.Areas covered: In this review we give a comprehensive overview of how sepsis occurs, which exogenous and endogenous factors might affect the immune-pathophysiological course of sepsis and finally how this knowledge translates into up-to-date definitions and therapeutic approaches.Expert commentary: Although new immunological mechanisms altering the course of sepsis have been identified recently, future research needs to address the limitations of experimental approaches, redirect the research focus into translational approaches, and finally evaluate personalized treatment strategies.
引用
收藏
页码:917 / 927
页数:11
相关论文
共 50 条
  • [31] International guidelines from the Surviving Sepsis Campaign. 2016 update
    Briegel, J.
    Moehnle, P.
    ANAESTHESIST, 2017, 66 (07): : 530 - 538
  • [32] Immunologic dissonance in the pathogenesis of sepsis
    盛志勇
    姚咏明
    林洪远
    中国危重病急救医学, 2006, (11) : 641 - 642
  • [33] Update on clinical results and correlative immunologic analysis of ipilimumab in patients with melanoma
    Wolchok, Jedd D.
    CANCER RESEARCH, 2012, 72
  • [35] Clinical and immunological aspects of microRNAs in neonatal sepsis
    Fatmi, Ahlam
    Chabni, Nafissa
    Cernada, Maria
    Vento, Maximo
    Gonzalez-Lopez, Maria
    Aribi, Mourad
    Pallardo, Federico V.
    Garcia-Gimenez, Jose Luis
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 145
  • [36] Internationale Leitlinien der Surviving Sepsis CampaignUpdate 2016International guidelines from the Surviving Sepsis Campaign2016 update
    J. Briegel
    P. Möhnle
    Der Anaesthesist, 2017, 66 : 530 - 538
  • [37] Clinical Update on Nursing Home Medicine: 2016
    Messinger-Rapport, Barbara J.
    Little, Milta O.
    Morley, John E.
    Gammack, Julie K.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2016, 17 (11) : 978 - 993
  • [38] Platelets in Sepsis: An Update on Experimental Models and Clinical Data
    Assinger, Alice
    Schrottmaier, Waltraud C.
    Salzmann, Manuel
    Rayes, Julie
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [39] Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma
    Shen, Alan
    Arbesman, Michelle
    Lodha, Roshan
    Rayman, Patricia
    Bungo, Brandon
    Ni, Ying
    Chan, Timothy
    Gastman, Brian
    Ko, Jennifer
    Diaz-Montero, C. Marcela
    Arbesman, Joshua
    Funchain, Pauline
    CLINICAL CANCER RESEARCH, 2024, 30 (03) : 564 - 574
  • [40] Immunologic Aspects of Endometriosis
    Young, Alexandria N.
    Maghsoudlou, Parmida
    King, Louise P.
    Rogers, Michael S.
    Hornstein, Mark D.
    CURRENT OBSTETRICS AND GYNECOLOGY REPORTS, 2024, 13 (01) : 24 - 36